Your browser doesn't support javascript.
loading
T cell and antibody functional correlates of severe COVID-19
Krystle K.Q. Yu; Stephanie Fischinger; Malisa T. Smith; Caroline Atyeo; Deniz Cizmeci; Caitlin R. Wolf; Erik D. Layton; Jennifer K. Logue; Melissa S. Aguilar; Kiel Shuey; Carolin Loos; Jingyou Yu; Nicholas Franko; Robert Y. Choi; Anna Wald; Dan H. Barouch; David M. Koelle; Douglas Lauffenburger; Helen Y. Chu; Galit Alter; Chetan Seshadri.
Afiliação
  • Krystle K.Q. Yu; Department of Medicine, University of Washington School of Medicine, Seattle, WA
  • Stephanie Fischinger; Ragon Institute of MGH, MIT and Harvard, Boston, MA PhD program in Immunology and Virology, University of Duisburg-Essen, Essen, Germany
  • Malisa T. Smith; Department of Medicine, University of Washington School of Medicine, Seattle, WA
  • Caroline Atyeo; Ragon Institute of MGH, MIT and Harvard, Boston, MA, USA PhD program in Virology, Division of Medical Sciences, Harvard University, Boston, MA
  • Deniz Cizmeci; Ragon Institute of MGH, MIT and Harvard, Boston, MA Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA
  • Caitlin R. Wolf; Department of Medicine, University of Washington School of Medicine, Seattle, WA
  • Erik D. Layton; Department of Medicine, University of Washington School of Medicine, Seattle, WA
  • Jennifer K. Logue; Department of Medicine, University of Washington School of Medicine, Seattle, WA
  • Melissa S. Aguilar; Department of Medicine, University of Washington School of Medicine, Seattle, WA
  • Kiel Shuey; Department of Medicine, University of Washington School of Medicine, Seattle, WA
  • Carolin Loos; Ragon Institute of MGH, MIT and Harvard, Boston, MA Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA
  • Jingyou Yu; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
  • Nicholas Franko; Department of Medicine, University of Washington School of Medicine, Seattle, WA
  • Robert Y. Choi; Providence Medical Group, Everett, WA
  • Anna Wald; Department of Medicine, University of Washington School of Medicine, Seattle, WA
  • Dan H. Barouch; Ragon Institute of MGH, MIT and Harvard, Boston, MA Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Bost
  • David M. Koelle; Department of Medicine, University of Washington School of Medicine, Seattle, WA
  • Douglas Lauffenburger; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA
  • Helen Y. Chu; Department of Medicine, University of Washington School of Medicine, Seattle, WA
  • Galit Alter; Ragon Institute of MGH, MIT and Harvard, Boston, MA
  • Chetan Seshadri; Department of Medicine, University of Washington School of Medicine, Seattle, WA
Preprint em En | PREPRINT-MEDRXIV | ID: ppmedrxiv-20235150
Artigo de periódico
Um artigo publicado em periódico científico está disponível e provavelmente é baseado neste preprint, por meio do reconhecimento de similaridade realizado por uma máquina. A confirmação humana ainda está pendente.
Ver artigo de periódico
ABSTRACT
Comorbid medical illnesses, such as obesity and diabetes, are associated with more severe COVID-19, hospitalization, and death. However, the role of the immune system in mediating these clinical outcomes has not been determined. We used multi-parameter flow cytometry and systems serology to comprehensively profile the functions of T cells and antibodies targeting spike, nucleocapsid, and envelope proteins in a convalescent cohort of COVID-19 subjects who were either hospitalized (n=20) or not hospitalized (n=40). To avoid confounding, subjects were matched by age, sex, ethnicity, and date of symptom onset. Surprisingly, we found that the magnitude and functional breadth of virus-specific CD4 T cell and antibody responses were consistently higher among hospitalized subjects, particularly those with medical comorbidities. However, an integrated analysis identified more coordination between polyfunctional CD4 T-cells and antibodies targeting the S1 domain of spike among subjects that were not hospitalized. These data reveal a functionally diverse and coordinated response between T cells and antibodies targeting SARS-CoV-2 which is reduced in the presence of comorbid illnesses that are known risk factors for severe COVID-19. Our data suggest that isolated measurements of the magnitudes of spike-specific immune responses are likely insufficient to anticipate vaccine efficacy in high-risk populations.
Licença
cc_by
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Cohort_studies / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Cohort_studies / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Preprint